Cyclo Therapeutics, Inc. - Warrant

Share · US23254X1101 · CYTHW (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

n/a

Share Float & Liquidity

Free Float 40,96 %

Shares Float 11,51 M

Shares Outstanding 28,11 M

Company Profile for Cyclo Therapeutics, Inc. - Warrant Share

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

AI Analysis of Cyclo Therapeutics, Inc. - Warrant

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Cyclo Therapeutics, Inc. - Warrant

No AI threads available for this company yet.

Company Data

Name Cyclo Therapeutics, Inc. - Warrant

Company Cyclo Therapeutics, Inc.

Symbol CYTHW

Website http://www.cyclotherapeutics.com

Primary Exchange

NASDAQ

ISIN US23254X1101

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO N. Scott Fine

Country United States of America

Currency USD

Employees 0,0 T

Address 6714 NW 16th Street, Gainesville

IPO Date 2020-12-18

Ticker Symbols

Name	Symbol
NASDAQ	CYTHW

More Shares

Investors who hold Cyclo Therapeutics, Inc. - Warrant also have the following shares in their portfolio:

CREDIT AGRICOLE CIB FINANCIAL SOLUTIONS IDX LKD INT RED SECS 25/10/25 Bond

TRATON FIN. 24/27 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog